Marketing-authorisation holder · Greece
Pharmathen S.A.
119 medicines in 5 countries, as authorisation holder, manufacturer and marketer.
Group structure
Other companies in the group
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Medicines
Every medicine in the registers under its name, current ones first.
1–25 of 119
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 61 | 38 | 23 | CompaniesAll medicines |
| Netherlands | 39 | 39 | 0 | CompaniesAll medicines |
| Italy | 11 | 11 | 0 | CompaniesAll medicines |
| European Union (EMA) | 6 | 3 | 3 | CompaniesAll medicines |
| Romania | 2 | 0 | 2 | CompaniesAll medicines |
Also in the registers of Croatia, Serbia, Singapore, United Kingdom
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Antimycotics for systemic useAnti-infectives for systemic use · ATC J02A
- Drugs for the treatment of bone diseasesMusculo-skeletal system · ATC M05B
- AntiepilepticsNervous system · ATC N03A
- Antithrombotic agentsBlood and blood-forming organs · ATC B01A
- ImmunosuppressantsAntineoplastic and immunomodulating agents · ATC L04A
Top substances
The active substances in most of its medicines.
- Fluconazole9 medicines
- Sitagliptin9 medicines
- Ibandronic acid8 medicines
- Aprepitant7 medicines
- Levetiracetam7 medicines
- Galantamine6 medicines
- Quetiapine6 medicines
- Dimethyl5 medicines
- Prasugrel5 medicines
- Rivaroxaban5 medicines
- Atorvastatin4 medicines
- Dabigatran etexilate4 medicines
- Deferasirox4 medicines
- Clopidogrel4 medicines
- Ranolazine4 medicines
- Tacrolimus4 medicines
- Leflunomide3 medicines
- Metformin3 medicines
- Voriconazole3 medicines
- Brinzolamide2 medicines
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- pharmathen
- pharmathen s a
- pharmathen sa
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
All 13 sources
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Group
- Pharmathen
- Headquarters
- Greece
- Medicines
- 119
- Countries
- 5
- Roles
- Authorisation holder, manufacturer and marketer